Navigation Links
Lilly Contributes $11.1 Million to United Way Annual Campaign
Date:11/13/2008

Lilly's gift makes up nearly 23% of fund raising goal for Central Indiana

INDIANAPOLIS, Nov. 13 /PRNewswire-FirstCall/ -- Eli Lilly and Company (NYSE: LLY) President and Chief Executive Officer John Lechleiter today presented an $11.1 million check to the United Way of Central Indiana for its and other United Way chapters' 2008 fundraising campaigns. The check represents the contributions of Lilly employees and retirees across the United States with a matching gift amount from the Lilly Foundation. Lilly's commitment represents nearly 23 percent of the United Way of Central Indiana's 2008 annual campaign goal.

"In the face of difficult and unprecedented economic conditions confronting all of us, Lilly exceeded its United Way fundraising goal by $100,000," said Lechleiter. "We're very proud of the dollar commitment we're making today. We're even more proud of the thousands of Lilly employees who support United Way agencies and services in their local communities through donations of their time and talents, as well as their financial resources."

In 2008, more than 450 Lilly employees served as tutors for United Way's ReadUP program, and more than 9,000 employees participated in the company's first-ever Global Day of Service, including 278 employees who supported projects benefiting United Way. Additionally, Lilly employees donated:

-- More than 21,000 school supplies to BackPack Attack

-- More than 1,600 bags of clothing to Goodwill Industries

-- More than 300 books

-- 500 blankets to the American Red Cross.

"Lilly's unwavering commitment to United Way of Central Indiana speaks to the dedication and passion of its employees," said Ellen Annala, president and chief executive officer of
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Emisphere Technologies, Inc. and Eli Lilly and Company Settle Ongoing Litigation
2. Lilly Declares Fourth-Quarter Dividend
3. Robert Conley, M.D. to Join Lilly; Will assume a neuroscience leadership role as a Distinguished Lilly Scholar
4. Lilly and BioMS Medical Announce Global Licensing and Development Agreement
5. Daiichi Sankyo, Lilly Submit New Drug Application for Investigational Antiplatelet Drug, Prasugrel, with U.S. Food and Drug Administration
6. In response to a New England Journal of Medicine article published yesterday and subsequent media coverage, Eli Lilly and Company issued the following statement:
7. Lilly Announces Termination of AIR Insulin Program
8. HistoRx and Lilly Extend, Expand AQUA(R) Analysis Partnership
9. Pelikan Technologies and Lilly Form Alliance to Promote Diabetes Education
10. Lilly Reports Solid First-Quarter Results
11. Lilly CEO Praises Massachusetts Leadership in Biotech, Urges Policy Prescriptions to Help Ensure States Investment Generates Dividends and Jobs

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)...RY, Nov. 6 /PRNewswire-FirstCall/ - Oncolytics Bio...the "Company") today announced updated results fro...atients with sarcomas metastatic to the lung in a ...Tissue Oncology Society Meeting held in Miami Beac...resentation, entitled "A Phase II Study of Intrave...
(Date:11/5/2009)...ERSBURG, Md., Nov. 5 Gen...ancial results for the third quarter ended Septemb...llion ($0.04 per share) for the three months ended... million ($0.08 per share) in the comparable quart..., 2009, GenVec,s net loss was $14.1 million ($0.15...
(Date:11/5/2009)...O CORDOVA, Calif., Nov. 5 /PRNewswire-FirstCall/ -...supplier of innovative products for processing and...for the first quarter of fiscal 2010. ,, For th...ported revenues of $5.2 million, a 15 percent incr...arter a year ago. The Company said the key contrib...
(Date:11/5/2009)...VALE, Calif., Nov. 5 Cep...cutives will be speaking at the following investor... via webcast. , , Credit Suisse He...Thursday, 12 November, 2009 at 10 a.m. Mountain Ti...ram, London, England, Tuesday, 1 D...
Breaking Biology Technology:Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 2Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 3GenVec Reports Third Quarter 2009 Financial Results 2GenVec Reports Third Quarter 2009 Financial Results 3GenVec Reports Third Quarter 2009 Financial Results 4GenVec Reports Third Quarter 2009 Financial Results 5GenVec Reports Third Quarter 2009 Financial Results 6ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 2ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 3ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 4ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 5ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 6ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 7ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 8Cepheid to Webcast Upcoming Financial Presentations 2
...EAST NORRITON, Pa., Feb. 27 Tengion Inc., a clini... the development of,neo-organs and neo-vessels, an...o its Board of Directors. Mr. Randall brings more ...ive, CFO and CEO at public and private,companies t...device,manufacturing and electronics industries., ...
...SOUTH SAN FRANCISCO, Calif., Feb. 27 Anesiva,Inc....aughlin, the company,s,chief executive officer, wi...ificant Investment Options in Healthcare Conferenc...., To access the live webcast or the subsequent a...om, go to the Investors page, and click on Events...
...RIO DE JANEIRO, Brazil, Feb. 26 One of,Brazil,s l...ofarma,Distribuidora de Produtos Farmaceuticos S.A...as just announced its results for the fourth quart...S FOR THE PERIOD, -- Profarma,s market share brea...ntage points above the share reached in the 3Q07 a...
Other Biology Technology:Tengion Appoints Jeff Randall to Board of Directors 2
(Date:11/4/2009)...,, CARLSBAD, Calif., Oct. 23 Ge...ure biosample management for genomic discovery, me...vid Wellis, Ph.D., GenVault,s President and CEO, w...e taking place on October 26th and 27th in La Joll...ill provide an overview of the company together wi...
(Date:11/4/2009)...,, NEW YORK, Oct. 27 Global Rai...mpany and advanced R&D laboratory, today annou...e and is prepared to actively commercialize its su...dge biometric security offerings. ,, During the...llions of dollars to develop and deploy a series o...
(Date:11/4/2009)...,, CARLSBAD, Calif., Nov. 4 Gen...hat William Brody, M.D., Ph.D., has joined its Boa...idential Chair of the Salk Institute, is an acclai...ior to joining the Salk Institute, Dr. Brody serve...e is a member of the National Academy of Engineeri...
Breaking Biology News(10 mins):GenVault Corporation to Present at the 2009 BIOCOM Investor Conference 2Global Rainmakers Brings Cutting-Edge Biometric Security Products to Reality 2Global Rainmakers Brings Cutting-Edge Biometric Security Products to Reality 3Dr. William Brody, President of the Salk Institute for Biological Studies, Appointed to GenVault's Board of Directors 2Dr. William Brody, President of the Salk Institute for Biological Studies, Appointed to GenVault's Board of Directors 3Brain Fitness Makes Boomers Age Younger 4605 1Brain Fitness Makes Boomers Age Younger 4605 2BioArts International Clones 9 11 Hero Dog Owner to Receive Five Cloned Puppies June 17 in Los Angeles 49158 1BioArts International Clones 9 11 Hero Dog Owner to Receive Five Cloned Puppies June 17 in Los Angeles 49158 2BioArts International Clones 9 11 Hero Dog Owner to Receive Five Cloned Puppies June 17 in Los Angeles 49158 3European Airports Actively Engaging on Reducing CO2 Despite the Crisis 12664 1European Airports Actively Engaging on Reducing CO2 Despite the Crisis 12664 2European Airports Actively Engaging on Reducing CO2 Despite the Crisis 12664 3
...n damage DNA, reducing its ability to replicate an...he development of skin cancers. However, not much ...s altered upon exposure to UV light. Now a group o...method to measure changes in the mechanical proper...r Marszalek and his colleagues have conducted sing...
...MS) tends to go into remission while women are pre...ing neurodegenerative disease, according to Univer...pregnancy-related hormone is responsible for rebui... In a paper to be published in the February 21 iss...rchers from the U of C,s Faculty of Medicine repor...
...ther, more widely used subjects of scientific stud... or mouse. But University of Illinois cell and dev...s it should be. As it turns out, the tiny, seeming... study of germ cells, precursors of eggs and sperm...arian Newmark studies, Schmidtea mediterranea, is ...
Other Biology News:Stretching DNA to the limit 2Pregnancy hormone key to repairing nerve cell damage 2Pregnancy hormone key to repairing nerve cell damage 3Study of planarians offers insight into germ cell development 2
Mycoplasma Testing from AbD Serotec
...Exonuclease-free Klenow Fragment is a genetically ...xonuclease activity has been removed, leaving only...f exonuclease activity makes Exo- Klenow Fragment ...ng of DNA probes by the random primed method, and ...
T4 RNA Ligase from Roche Applied Science
T7 RNA Polymerase from Roche Applied Science
Biology Products: